Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
about
High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcomaKey role for ubiquitin protein modification in TGFβ signal transductionCD109 plays a role in osteoclastogenesisMutations in CPAMD8 Cause a Unique Form of Autosomal-Recessive Anterior Segment DysgenesisThe type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.Transforming growth factor: beta signaling is essential for limb regeneration in axolotlsMolecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disordersCurrent perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future InvestigationCD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.Genomic and epigenomic integration identifies a prognostic signature in colon cancerDynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types.Cellular and molecular pathology of HTS: basis for treatment.Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.Novel Identity and Functional Markers for Human Corneal Endothelial Cells.Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinomaDetection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.Suppression of skin tumorigenesis in CD109-deficient mice.Metastasis-associated cell surface oncoproteomics.Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics.Patterns of differentially expressed genes in oral mucosal lesions visualised under autofluorescence (VELscope(™) ).Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.Signaling Receptors for TGF-β Family Members.Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk.CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.MicroRNA-23b-3p regulates human keratinocyte differentiation through repression of TGIF1 and activation of the TGF-ß-SMAD2 signalling pathway.Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.CD109 expression in basal-like breast carcinoma.High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring.Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing.CD109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma.
P2860
Q21132376-62539964-8284-47D2-948E-72DD7769FF9BQ26824916-1D7A7AC6-32FB-422F-8C51-86270289C8C3Q28505691-C392675E-E3F2-4604-8F72-5ACCDB28ED8CQ28910384-57B8D7CF-4D69-4AED-869A-65724B3C536EQ30582833-05251362-F184-4E9A-ADCD-B56340C9CF4DQ33307528-12639F35-6FAF-4E48-B7C7-3CC4756CC95DQ33391693-DC6BDE63-1A75-4E87-82FE-1926B58B8FD8Q33441520-EC4414CF-A2CB-4C2F-BEA2-DC70D8CD49A3Q34520504-48211D32-2627-4636-92A3-E479FF1C2066Q34627087-C75D50AF-0337-4431-BA99-8585BD875FC4Q34703792-49650CF3-FF07-46E8-AE29-B3F87B5CEFCBQ34801833-5706414F-CA61-461B-BC01-C1290F5A02F3Q35583066-D19CCF95-B6F5-46F5-9B54-EE38C8C66504Q36246124-6F1C7927-4AFF-4963-9EA5-7D44FF5331FAQ36428301-891350F9-1742-4CF0-B44F-6F753322E4A2Q36641017-ED79D555-7681-46BD-9984-CA13CF2BBD37Q36922428-A2E56B98-7967-4A3B-8DE7-898302FF3212Q36925909-B48DA737-E13B-44E6-96A9-D4021CB42391Q36944541-81C20E77-BB28-4098-B758-8F92BF1B9094Q37301807-8F14D404-3EDE-43D7-B042-7EC7489E8939Q37439207-BA92704A-7B8B-4912-9A63-BF46574DD47BQ37633338-F92EFBEA-6BCE-4ABC-937D-58E459FA112AQ37696223-68C36331-1F7C-4423-A4E5-ED6F86587572Q38060714-5EE3AB27-EE93-494F-9F56-D58CD531E3C8Q38423146-7AFB3F49-1BB2-4767-87F0-051D408A6DD9Q38452571-17AA7BC2-C376-43E4-A8F0-76631B4A7627Q38716717-1A162358-CAE9-45BB-B6B3-4BCB16523D62Q38723891-EFF6BA06-B4E3-4D63-8240-1572043E46B4Q38915720-3ABDCB6E-FD4A-44E2-BF0C-9462F1C1ABEDQ39455041-CE1B170F-4F00-495D-8940-C5D2A98CAEE5Q39478295-5C7D50B1-142E-478E-A48A-42852A7A4847Q39549018-29CD34D0-FA98-495A-9BF2-E9032ABF21A4Q39680878-48428205-F9DA-450D-B42B-20A0B0EAF6BBQ39747986-FB63A564-BB32-4DA3-BDAF-D36595E199E1Q42170620-EB47BA2C-5445-44E7-9A5B-C7437E8E6C11Q42519941-7B8BD5C4-C084-4F5B-91D2-80E438FDC7C0Q42738187-572B735D-5E08-4432-9271-13E696274846Q42742537-932593E8-8CD2-42A8-BCFB-6AE064860DE2Q42829097-8DFBD1EB-98DD-4541-95BC-273EA91B36C7Q46042480-6F2CDC1A-76DF-47DC-A4BF-92EB58B94068
P2860
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@ast
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en-gb
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@nl
type
label
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@ast
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en-gb
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@nl
prefLabel
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@ast
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en-gb
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@nl
P2093
P921
P3181
P356
P1433
P1476
Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes
@en
P2093
Anie Philip
Anne Marcoux
Betty Y Y Tam
Kenneth W Finnson
Pierre Lepage
Stephane Roy
P304
P3181
P356
10.1096/FJ.05-5229FJE
P407
P577
2006-06-05T00:00:00Z